* Bal Pharma Limited clarified the outcome of the Board Meeting held on 11 August 2025, regarding the merger of its subsidiary, Lifezen Healthcare Pvt Ltd. * The Board of Directors considered the merger proposal but decided to defer the matter due to inadequate data. * The management has been instructed to re-present the proposal with all necessary details for an informed decision.
